Palatin Technologies (PTN) Total Liabilities (2011 - 2026)
Palatin Technologies' (PTN) quarterly Total Liabilities came in at $2.6 million in Q1 2026, down 73.97% YoY from $10.1 million in Q1 2025, and down 59.25% on a QoQ basis from $6.5 million in Q4 2025.
Palatin Technologies (PTN) Total Liabilities (2011 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 15 years of Total Liabilities data on file, last reported at $2.6 million in Q1 2026.
- Quarterly Total Liabilities fell 73.97% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 73.97% YoY) and the FY2025 annual result came in at $8.0 million, down 25.89% from the prior year.
- Total Liabilities fell to $2.6 million in Q1 2026, from $6.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $24.5 million in Q4 2023 to a low of $2.6 million in Q1 2026.
- A 5-year average of $13.2 million and a median of $11.1 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities soared 56.82% — and 2026, when it tumbled 73.97%.
- Tracing PTN's Total Liabilities over 5 years: stood at $15.6 million in 2022, then soared by 56.82% to $24.5 million in 2023, then sank by 56.39% to $10.7 million in 2024, then slumped by 39.56% to $6.5 million in 2025, then slumped by 59.25% to $2.6 million in 2026.
- The last three Total Liabilities figures came in at $2.6 million (Q1 2026), $6.5 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | 10.03 Bn |
| 10 | Palatin Technologies | 40.68 Mn | 40.68 Mn | - | 2.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.63 Mn |
| Dec 31, 2025 | 6.46 Mn |
| Sep 30, 2025 | 8.22 Mn |
| Jun 30, 2025 | 8.04 Mn |
| Mar 31, 2025 | 10.12 Mn |
| Dec 31, 2024 | 10.69 Mn |
| Sep 30, 2024 | 11.10 Mn |
| Jun 30, 2024 | 10.85 Mn |
| Mar 31, 2024 | 9.83 Mn |
| Dec 31, 2023 | 24.52 Mn |
| Sep 30, 2023 | 16.14 Mn |
| Jun 30, 2023 | 19.66 Mn |
| Mar 31, 2023 | 16.02 Mn |
| Dec 31, 2022 | 15.63 Mn |
| Sep 30, 2022 | 19.19 Mn |
| Jun 30, 2022 | 19.80 Mn |
| Mar 31, 2022 | 15.73 Mn |
| Dec 31, 2021 | 17.80 Mn |
| Sep 30, 2021 | 16.76 Mn |
| Jun 30, 2021 | 17.65 Mn |